FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Pristiq news from FierceBiotech

News

FDA OKs Wyeth's antidepressant Pristiq

Wyeth announced late Friday that it won FDA approval for Pristiq, its next-generation version of the antidepressant Effexor. Wyeth was looking for an approval of Pristiq to offset the Read more...

Wyeth presents Pristiq data

Wyeth is revealing more Pristiq data today from two Phase III clinical studies of Pristiq. Earlier this year, the Read more...
Tags: Phase III   FDA   Wyeth   Pristiq  

Wyeth's Pristiq shows benefits in clinical trial

Wyeth says that the nonhormonal desvenlafaxine, or Pristiq, demonstrated significant efficacy against hot flashes and night sweats in a clinical trial--but noted that high blood pressure and other Read more...
Tags: FDA   Wyeth   blood pressure   Pristiq   Menopause  

FDA demands more data on Wyeth's Pristiq

Wyeth was effectively stiff-armed by the FDA in its application for Pristiq, the first non-hormonal therapy to treat menopausal symptoms. In an approvable letter, regulators told the company that Read more...
Tags: FDA   Wyeth   depression   FDA update   Pristiq   Menopause  

Press Releases

PRESS RELEASE: Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms

Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo COLLEGEVILLE, Pa., Oct. 15 -- Wyeth Pharmaceuticals, a Read more...

Get more Pristiq coverage at: